Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Cystic Fibrosis
Interventions
BEHAVIORAL

Adherence dashboard motivational interviewing

These data will be aggregated and displayed graphically in weekly intervals. Adherence will be displayed as percentage and timing percentage within a set criterion of prescribed inter-dose interval. Drug holidays, operationally defined as missing two or more consecutive doses will be displayed along with average length. Patient self-reported adherence information, collected via handheld (i.e, smart phone, tablet, laptop) application will be displayed as percentage and timing percentage on the dashboard. Review of dashboard weekly with investigator for motivational interviewing

Trial Locations (1)

93003

Pediatric Diagnostic Center, Ventura

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

Landon Pediatric Foundation

OTHER